Mohamed Al‐Ibrahim

1.6k total citations
27 papers, 1.1k citations indexed

About

Mohamed Al‐Ibrahim is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Mohamed Al‐Ibrahim has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in General Health Professions. Recurrent topics in Mohamed Al‐Ibrahim's work include Viral gastroenteritis research and epidemiology (3 papers), Respiratory viral infections research (3 papers) and Bacillus and Francisella bacterial research (3 papers). Mohamed Al‐Ibrahim is often cited by papers focused on Viral gastroenteritis research and epidemiology (3 papers), Respiratory viral infections research (3 papers) and Bacillus and Francisella bacterial research (3 papers). Mohamed Al‐Ibrahim collaborates with scholars based in United States, Switzerland and Germany. Mohamed Al‐Ibrahim's co-authors include Wilbur H. Chen, Paul M. Mendelman, Robert L. Atmar, David Y. Graham, Jennifer Ferreira, Antone R. Opekun, Charles C. Richardson, Clayton Harro, Mary K. Estes and David I. Bernstein and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and The Journal of Infectious Diseases.

In The Last Decade

Mohamed Al‐Ibrahim

26 papers receiving 1.0k citations

Peers

Mohamed Al‐Ibrahim
Leonard R. Friedland United States
Jin Xu China
Luc Hessel France
Nuran Salman Türkiye
Milford H. Hatch United States
I. L. Chrystie United Kingdom
Mohamed Al‐Ibrahim
Citations per year, relative to Mohamed Al‐Ibrahim Mohamed Al‐Ibrahim (= 1×) peers Christopher J. Harrison

Countries citing papers authored by Mohamed Al‐Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Mohamed Al‐Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Al‐Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Al‐Ibrahim more than expected).

Fields of papers citing papers by Mohamed Al‐Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Al‐Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Al‐Ibrahim. The network helps show where Mohamed Al‐Ibrahim may publish in the future.

Co-authorship network of co-authors of Mohamed Al‐Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Al‐Ibrahim. A scholar is included among the top collaborators of Mohamed Al‐Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Al‐Ibrahim. Mohamed Al‐Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Ibrahim, Mohamed, B. Keck, Stephen English, et al.. (2025). P-1117. An Open-label Phase 1 Study in Healthy Adult Male Participants to Investigate the Absorption, Metabolism, and Excretion of [14C]-Rifaquizinone Following a Single Intravenous Administration. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
2.
Mercer, Laina D., Arlene C. Seña, E. Ross Colgate, et al.. (2025). Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial. The Lancet Infectious Diseases. 25(12). 1363–1376. 1 indexed citations
3.
Nussbaum, Jesse C., Radha Railkar, Jeffrey R. Sachs, et al.. (2023). Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults. Vaccine. 41(44). 6488–6501. 12 indexed citations
4.
Huynh, Christine, Daniel S. Strasser, Mohamed Al‐Ibrahim, et al.. (2021). A Multipurpose First‐in‐Human Study With the Novel CXCR7 Antagonist ACT‐1004‐1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker. Clinical Pharmacology & Therapeutics. 109(6). 1648–1659. 9 indexed citations
5.
Al‐Ibrahim, Mohamed, Steven D. Dong, Christopher Gast, et al.. (2021). A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model. PLoS neglected tropical diseases. 15(11). e0009969–e0009969. 7 indexed citations
7.
Atmar, Robert L., Frank Baehner, Jakob P. Cramer, et al.. (2019). Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination. The Journal of Infectious Diseases. 220(4). 603–614. 22 indexed citations
8.
Adler, Stuart P., Nicole Lewis, Mark P. Christiansen, et al.. (2017). Phase 1 Clinical Trial of a Replication-Defective Human Cytomegalovirus (CMV) Vaccine. Open Forum Infectious Diseases. 4(suppl_1). S308–S309. 5 indexed citations
9.
Heald, Alison E., Jay S. Charleston, Patrick L. Iversen, et al.. (2015). AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. New England Journal of Medicine. 373(4). 339–348. 40 indexed citations
10.
Lawitz, Eric, Mark Sulkowski, Ira M. Jacobson, et al.. (2013). Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics. Antiviral Research. 99(3). 214–220. 26 indexed citations
11.
Atmar, Robert L., David I. Bernstein, Clayton Harro, et al.. (2011). Norovirus Vaccine against Experimental Human Norwalk Virus Illness. New England Journal of Medicine. 365(23). 2178–2187. 363 indexed citations
12.
Smith, Larry, Mary K. Wloch, Ming Ye, et al.. (2010). Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin. Vaccine. 28(13). 2565–2572. 113 indexed citations
13.
Oliver, Marc, et al.. (2004). Terrorism-Preparedness Training for Non-Clinical Hospital Workers: Tailoring Content and Presentation to Meet Workers’ Needs. Journal of Occupational and Environmental Medicine. 46(7). 668–676. 12 indexed citations
14.
Hooper, Frank J., et al.. (1998). Relationship of Self-Reported Oral Health and Nutritional Risk Among Hospitalized Older Adults. Journal of Public Health Management and Practice. 4(3). 57–63. 2 indexed citations
15.
Simberkoff, Michael S., Anne Cross, Mohamed Al‐Ibrahim, et al.. (1986). Efficacy of Pneumococcal Vaccine in High-Risk Patients. New England Journal of Medicine. 315(21). 1318–1327. 309 indexed citations
16.
Al‐Ibrahim, Mohamed, et al.. (1981). Nutritional and pulmonary function assessment in patients with chronic obstructive lung disease. Nutrition Research. 1(5). 461–466. 7 indexed citations
17.
Freeman, Richard W., et al.. (1981). Planning Health Services for a City Jail: Impact of Contractual Services on Men??s Sick Call. Medical Care. 19(4). 410–418. 3 indexed citations
18.
Hoover, David L. & Mohamed Al‐Ibrahim. (1980). A modified microassay for human macrophage activation. Cellular Immunology. 53(1). 182–194. 2 indexed citations
19.
Al‐Ibrahim, Mohamed, Fred Valentine, & H. Sherwood Lawrence. (1978). Activated lymphocytes depress phagocytosis of latex particles by human monocyte-macrophages. Cellular Immunology. 41(2). 217–230. 9 indexed citations
20.
Al‐Ibrahim, Mohamed, Ramesh Chandra, Raj Kishore, Fred Valentine, & H. Sherwood Lawrence. (1976). A micromethod for evaluating the phagocytic activity of human macrophages by ingestion of radio-labelled polystyrene particles. Journal of Immunological Methods. 10(2-3). 207–218. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026